Susceptibilities of Yersinia pestis Strains to 12 Antimicrobial Agents
- 1 July 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (7) , 1995-1996
Abstract
Ninety-two strains of Yersinia pestis recovered over a 21-year period were evaluated for susceptibility to traditional and newer antimicrobial agents. In vitro resistance was noted only against rifampin and imipenem (∼20% of strains). The most active compounds (MIC at which 90% of the isolates tested are inhibited) against Y. pestis were cefixime, ceftriaxone, trimethoprim-sulfamethoxazole, and trovafloxacin.Keywords
This publication has 8 references indexed in Scilit:
- Multidrug Resistance inYersinia pestisMediated by a Transferable PlasmidNew England Journal of Medicine, 1997
- Yersinia pestis--etiologic agent of plague.1997
- Yersinia pestis--etiologic agent of plagueClinical Microbiology Reviews, 1997
- In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focusAntimicrobial Agents and Chemotherapy, 1996
- In vitro antimicrobial susceptibilities of strains of Yersinia pestisAntimicrobial Agents and Chemotherapy, 1995
- From the Centers for Disease Control and Prevention. Human plague--India, 1994.1994
- Human Plague—India, 19941994
- Pneumonic plague--Arizona, 1992.1992